|
101 |
Extension of timeline to submit the proposal for Project Management Agency (PMA) for Assistance to Medical Device Clusters for Common Facilities (AMD-CF) Scheme |
|
|
102 |
Report on Strategy for Leveraging ASEAN FTA and Trade Potential with the Middle East Countries for Pharma Sector in India |
|
|
103 |
Report on Assessment of skill requirement of Indian Pharma Industry |
|
|
104 |
Report on Final Boosting of Medical Devices Industry |
|
|
105 |
Report on Survey for Novel/ Innovative and Cost-effective Technologies for Productoion of APIs |
|
|
106 |
Report on Survey of Medical Devices Clusters |
|
|
107 |
Report on Survey of Pharma Clusters |
|
|
108 |
Lateral Recruitment for 20 posts of JS/Director/DS -reg |
|
|
109 |
Amendment in the Operational Guidelines for the Scheme for Promotion of Medical Device Parks w.r.t utilization of previous instalment to claim the subsequent instalment - reg. |
|
|
110 |
Invitation of Tender for selection of CPSEs/Public Financial Institutions for providing services of Project Management Agency (PMA) for the Scheme (AMD-CF) |
|
|
111 |
List of Approved Applicants under Production Linked Incentive (PLI) Scheme for Pharmaceuticals - Dated 3rd May, 2023 |
|
|
112 |
Gazette Notification National Medical Device Policy 2023 |
|
|
113 |
List of Applicants Approved under Production Linked Incentive Scheme for Promoting Domestic Manufacturing of Medical Devices - Dated 25th April, 2023 |
|
|
114 |
NIPER Research Compendium |
|
|
115 |
List of Approved Applicants under Production Linked Incentive (PLI) Scheme for Bulk Drug - Dated 22nd March, 2023 |
|
|
116 |
Extension of timeline for submission of application till 08.04.2023 under PLI Scheme for Medical Devices. |
|
|
117 |
Annual Report 2022-23 -reg. |
|
|
118 |
Amendment in the Operational Guidelines for the Production Linked Incentive (PU) Scheme for Pharmaceuticals regarding the Scheme Selection and Steering Committee (SSSC) to regularly monitor the progress of implementation - reg. |
|
|
119 |
Revised Guidelines for the Production Linked Incentive (PLI) Scheme for Promoting Domestic Manufacturing of Medical Devices |
|
|
120 |
Required Modifications in the Guidelines of Production Linked Incentive Scheme for Promoting Domestic Manufacturing of Medical Devices (PLI MD) to invite applications for the eligible product as per Annexure-1A for Category-B applicant- reg. |
|
|
121 |
Invitation of Applications from eligible Category-B Applicants under the Revised guidelines / corrigendum dt. 25 02.2023 of Production Linked Incentive (PLI) Scheme for Promoting Domestic Manufacturing of Medical Devices |
|
|
122 |
Payment of Honorarium to Members of National Institutes of Pharmaceutical Education & Research (NIPER) Council - regarding |
|
|
123 |
Guidelines for Hiring of Young Professionals (non-tech) on contract basis in the Department of Pharmaceuticals-reg. |
|
|
124 |
Guidelines for Hiring of Non-Technical Consultants on contract basis in the Department of Pharmaceuticals-reg. |
|
|
125 |
Guidelines for Hiring of Technical Consultants/Young Professionals (Tech.) on contract basis in the Department of Pharmaceuticals-regarding. |
|
|
126 |
Modification of certain clauses of the PTUAS Sub-scheme of the Scheme 'Strengthening of Pharmaceuticals Industry'-regarding |
|
|
127 |
Update on PLI for Bulk Drug as on 30.12.2022 |
|
|
128 |
Seeking Comments/views/suggestions from Stakeholders on Framing of Recruitment Rules for the post of Staff Car Driver in Department of Pharmaceuticals - reg |
|
|
129 |
Extension of Timeline for Invitation of Applications from eligible Category B Applicants under the revised guidelines of PLI Scheme for Promoting Domestic Manufacturing of Medical Devices dated 18.8.2022 - till 21.11.2022- reg. |
|
|
130 |
Amendment in the Operational Guidelines for the Production Linked Incentive (PLI) Scheme for Pharmaceuticals - reg |
|
|
131 |
Extension of one week beyond 30.9.2022 for submission of application under the sub-scheme 'Assistance to Pharmaceutical Industry for Common Facilities (APICF)' - reg |
|
|
132 |
Constitution of High Level Committee to consider various issues pertaining to UCPMP and examine the requirement for a legally enforceable mechanism for regulating marketing practices by Pharma Companies-regarding |
|
|
133 |
Frequently Asked Questions (FAQs)- Pharmaceutical Technology Upgradation Assistance Scheme |
|
|
134 |
Frequently Asked Questions (FAQs)- Assistance to Pharmaceutical Industry for Common Facilities (API-CF) |
|
|
135 |
Amendment to the Order dated 21st January, 2019 with respect to constitution of Standing Committee on Affordable Medicines and Health Products (SCAMPH) - Regarding |
|
|
136 |
14 सितम्बर, 2022 को हिन्दी दिवस के उपलक्ष्य में सचिव (औषध) का संदेश |
|
|
137 |
Details of Applicants approved under Production Linked Incentive (PLI) Scheme for Pharmaceuticals |
|
|
138 |
Message from Honorable Minister (C&F) on Swachhta Pakhwada During 1-15 September 2022 |
|
|
139 |
Message from Honorable MoS (C&F) on Swachhta Pakhwada During 1-15 September 2022 |
|
|
140 |
Invitation of Applications from eligible Category B Applicants under the revised guidelines of Production Link Incentive (PU) Scheme for Promoting Domestic Manufacturing of Medical Devices dated 18.8.2022 from 1st September 2022 to 31st October 2022 - reg |
|
|
141 |
Corrigendum-Hiring of Young Professionals in the Department of Pharmaceuticals on contract basis. |
|
|
142 |
Revised Guidelines for the Production Linked Incentive (PLI) Scheme for Promoting Domestic Manufacturing of Medical Devices |
|
|
143 |
Hiring of Young Professionals in the Department of Pharmaceuticals on contract basis - regarding |
|
|
144 |
List of Approved Applicants under Production Linked Incentive (PLI) Scheme for Bulk Drug Dated 8th August, 2022 |
|
|
145 |
Seeking the details of domestic manufacturers of the inputs required for manufacture of Vaccines and Biopharmaceuticals. |
|
|
146 |
Corrigendum of PLI Scheme for Bulk Drug- Dated 26th July, 2022 |
|
|
147 |
Invitation of applications for the eligible product Vitamin B1,through chemical synthesis route under Production Linked Incentive (PLI) Scheme for Bulk Drug |
|
|
148 |
Guidelines for the Scheme Strengthening of Pharmaceuticals Industry (SPI)- Notification of the modifications of the few clauses in the GLs - regarding |
|
|
149 |
Filling up the post of Director (Finance) in Bengal Chemicals & Pharmaceuticals Ltd.(BCPL) through PESB selection mode.- regarding |
|
|
150 |
O.M. dated 02.05.2022 to Central Procurement Agencies to exercise due diligence on the claims of the local manufacturers while proceeding for the procurement |
|
औषध विभाग
Department of
